CBLL CeriBell, Inc.
23.48USD-3.53%Mkt Cap: 901.12M $P/E: —1d ago
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the ac…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap901.12M USD
Enterprise Value826.77M USD
Revenue (TTM)101.96M USD
Gross Profit78.27M USD
Net Income (TTM)-53.41M USD
Revenue/Share2.73 USD
Last Price23.48 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees327
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-15.09
PEG—
EV/EBITDA-12.02
EV/Revenue8.11
P/S9.16
P/B7.25
EPS (TTM)-1.72
EPS (Forward)-1.61
52W Range
10.8585% of range25.63
52W High25.63 USD
52W Low10.85 USD
Profitability
Gross Margin87.89%
Oper. Margin-71.11%
EBITDA Margin-67.48%
Profit Margin-59.97%
ROE-34.38%
ROA-27.28%
Growth
Revenue Growth32.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-40.81M USD
CapEx (TTM)767.00K USD
FCF Margin-32.41%
FCF Yield-3.67%
Net Debt-107.35M USD
Net Debt/EBITDA1.56
Balance Sheet
Debt/Equity0.14
Current Ratio9.18
Quick Ratio8.45
Book Value/Sh3.36 USD
Cash/Share3.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.57 USD
Upside (mean)+21.7%
Target Range24.00 USD – 33.00 USD
24.00+21.7% to mean33.00
# Analysts7
Ownership
Shares Out.38.38M
Float26.55M
Insiders11.84%
Institutions88.31%
Short Interest
Short Ratio5.6d
Short % Float7.27%
Short % Out.4.74%
Shares Short1.82M
Short (prev mo.)2.10M
Technical
SMA 5022.78 (+3.1%)
SMA 20020.38 (+15.2%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)325.84K
Avg Vol (10d)290.62K
Technical Indicators
RSI (14)47.0
MACD0.2105
MACD Signal0.3569
MACD Hist.-0.1464
BB Upper25.24 USD
BB Middle24.18 USD
BB Lower23.13 USD
BB Width8.73%
ATR (14)0.9279 USD
Vol Ratio (20d)0.85x